EP1874340A4 - Elastinschützende polyphenole und verfahren zu ihrer verwendung - Google Patents

Elastinschützende polyphenole und verfahren zu ihrer verwendung

Info

Publication number
EP1874340A4
EP1874340A4 EP06824685A EP06824685A EP1874340A4 EP 1874340 A4 EP1874340 A4 EP 1874340A4 EP 06824685 A EP06824685 A EP 06824685A EP 06824685 A EP06824685 A EP 06824685A EP 1874340 A4 EP1874340 A4 EP 1874340A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
polyphenolics
elastin
protective polyphenolics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP06824685A
Other languages
English (en)
French (fr)
Other versions
EP1874340A2 (de
Inventor
Felipe Jimenez
Thomas Mitts
Aleksander Hinek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Human Matrix Sciences LLC
Original Assignee
Hospital for Sick Children HSC
Human Matrix Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC, Human Matrix Sciences LLC filed Critical Hospital for Sick Children HSC
Publication of EP1874340A2 publication Critical patent/EP1874340A2/de
Publication of EP1874340A4 publication Critical patent/EP1874340A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
EP06824685A 2005-03-29 2006-03-29 Elastinschützende polyphenole und verfahren zu ihrer verwendung Ceased EP1874340A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66596605P 2005-03-29 2005-03-29
US75882106P 2006-01-13 2006-01-13
PCT/US2006/012027 WO2007030145A2 (en) 2005-03-29 2006-03-29 Elastin protective polyphenolics and methods of using the same

Publications (2)

Publication Number Publication Date
EP1874340A2 EP1874340A2 (de) 2008-01-09
EP1874340A4 true EP1874340A4 (de) 2010-06-30

Family

ID=37836298

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06824685A Ceased EP1874340A4 (de) 2005-03-29 2006-03-29 Elastinschützende polyphenole und verfahren zu ihrer verwendung

Country Status (3)

Country Link
EP (1) EP1874340A4 (de)
CA (1) CA2603102C (de)
WO (1) WO2007030145A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283349A1 (de) * 1987-02-20 1988-09-21 Jean-Louis Lamaison Verfahren zur Herstellung von Gerbstoffen aus Pflanzen, kosmetologische und pharmazeutische Zubereitung, die diesen durch dieses Verfahren hergestellten Gerbstoff enthält
FR2768927A1 (fr) * 1997-10-01 1999-04-02 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
WO2000064472A1 (en) * 1999-04-22 2000-11-02 Howard Murad Methods and compositions for treating dermatological disorders with fruit extracts
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
US20040120918A1 (en) * 2003-05-12 2004-06-24 Sederma S.A.S. Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides
US20040162232A1 (en) * 2003-02-14 2004-08-19 Thomas Mitts Elastin digest compositions and methods utilizing same
WO2005118783A1 (en) * 2004-05-28 2005-12-15 Human Matrix Sciences, Llc Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63313707A (ja) * 1987-06-16 1988-12-21 Seven Kagaku:Kk 皮膚化粧料
JP3393559B2 (ja) * 1993-10-15 2003-04-07 株式会社ノエビア 皮膚外用剤
JP2001072571A (ja) * 1999-09-08 2001-03-21 Noevir Co Ltd 皮膚外用剤
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
JP2002205913A (ja) * 2001-01-10 2002-07-23 Ichimaru Pharcos Co Ltd 化粧料組成物
DE50111204D1 (de) * 2001-08-18 2006-11-23 Cognis Ip Man Gmbh Wirkstoffmischungen
JP2003128511A (ja) * 2001-10-18 2003-05-08 Ichimaru Pharcos Co Ltd 皮膚老化防止剤
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
JP2006160685A (ja) * 2004-12-09 2006-06-22 Jc Community:Kk 経口用皮膚老化予防・改善剤
US7566693B2 (en) * 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283349A1 (de) * 1987-02-20 1988-09-21 Jean-Louis Lamaison Verfahren zur Herstellung von Gerbstoffen aus Pflanzen, kosmetologische und pharmazeutische Zubereitung, die diesen durch dieses Verfahren hergestellten Gerbstoff enthält
FR2768927A1 (fr) * 1997-10-01 1999-04-02 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
WO2000064472A1 (en) * 1999-04-22 2000-11-02 Howard Murad Methods and compositions for treating dermatological disorders with fruit extracts
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
US20040162232A1 (en) * 2003-02-14 2004-08-19 Thomas Mitts Elastin digest compositions and methods utilizing same
US20040120918A1 (en) * 2003-05-12 2004-06-24 Sederma S.A.S. Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides
WO2005118783A1 (en) * 2004-05-28 2005-12-15 Human Matrix Sciences, Llc Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BUNDA S ET AL: "Fluctuations of intracellular iron modulate elastin production", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M409897200, vol. 280, no. 3, 21 January 2005 (2005-01-21), pages 2341 - 2351, XP002346489, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2007030145A2 (en) 2007-03-15
EP1874340A2 (de) 2008-01-09
WO2007030145A3 (en) 2009-04-16
CA2603102C (en) 2015-08-11
CA2603102A1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
IL228770A0 (en) processes and intermediates
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
EP1846419A4 (de) Alkyloxysubstituierte thiazolochinoline und thiazolonaphthyridine
EP1895838A4 (de) Zusammensetzungen und verfahren
EP1951680A4 (de) Neue 2-aminopyrimidonderivate und deren verwendung
GB0512940D0 (en) Compounds and their use
IL189609A0 (en) 4-substituted pyrrolidin-2-ones and their use
IL191072A0 (en) Therapeutic compositions and methods
GB2430971B (en) Gas-tight and liquid-tight protective suit
EP1951682A4 (de) Neue 2-aminopyrimidon- oder 2-aminopyridinonderivate und deren verwendung
EP1861218A4 (de) Hülse und verschlussmutter
IL189252A0 (en) Dihydroxyanthraquinones and their use
IL228531A0 (en) Mucin hypersecretion inhibitors based on mans peptide structure and their uses
EP1912921A4 (de) Verbindungen auf tetraazaporphyrinbasis und deren verwendungen
EP1921066A4 (de) Pyridylphenolverbindung und ihre verwendung
EP1841730A4 (de) Cathepsin-k-inhibitoren und atherosklerose
IL185412A0 (en) Plant extracts and methods and uses therefore
EP1858509A4 (de) Neue cathepsin-c-hemmer und ihre verwendung
EP1874340A4 (de) Elastinschützende polyphenole und verfahren zu ihrer verwendung
GB0520935D0 (en) Integrated processor-template-system and project
GB0501348D0 (en) Compositions and methods
ZA200805245B (en) Combination of AXD2171 and pemetrexed
GB0502843D0 (en) Jig-was and jig-will
ZA200706741B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
GB2425708B (en) Bracelet and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071010

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20090416

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/08 20060101ALI20090417BHEP

Ipc: A61K 33/32 20060101ALI20090417BHEP

Ipc: A61P 17/16 20060101ALI20090417BHEP

Ipc: A61K 31/7024 20060101ALI20090417BHEP

Ipc: A61K 38/39 20060101ALI20090417BHEP

Ipc: A61K 31/366 20060101AFI20090417BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100602

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/00 20060101ALI20100527BHEP

Ipc: A61K 8/64 20060101ALI20100527BHEP

Ipc: A61K 8/60 20060101ALI20100527BHEP

Ipc: A61K 8/49 20060101ALI20100527BHEP

Ipc: A61K 8/19 20060101ALI20100527BHEP

Ipc: A61K 33/34 20060101ALI20100527BHEP

Ipc: A61K 33/26 20060101ALI20100527BHEP

Ipc: A61K 31/39 20060101ALI20100527BHEP

Ipc: A61K 45/06 20060101ALI20100527BHEP

Ipc: A61Q 19/08 20060101ALI20100527BHEP

Ipc: A61K 33/32 20060101ALI20100527BHEP

Ipc: A61P 17/16 20060101ALI20100527BHEP

Ipc: A61K 31/7024 20060101ALI20100527BHEP

Ipc: A61K 38/39 20060101ALI20100527BHEP

Ipc: A61K 31/366 20060101AFI20090417BHEP

17Q First examination report despatched

Effective date: 20110921

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140320